D. Haigh

发表

Management of Staphylococcus aureus-infected atopic eczema

D. Haigh, 2014 .

[[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.

Stephen A. Smith, M. Cawthorne, S. Smith, 1994, Journal of medicinal chemistry.

Non thiazolidinedione antihyperglycaemic agents. 2: α-Carbon substituted β-phenylpropanoic acids1

David Haigh, Stephen A. Smith, M. Cawthorne, 1996 .

Non-thiazolidinedione antihyperglycaemic agents. Part 5: Asymmetric aldol synthesis of (S)-(−)-2-oxy-3-arylpropanoic acids

D. Eggleston, R. Haltiwanger, H. Birrell, 1999 .

Non thiazolidinedione antihyperglycaemic agents. 1: α-Heteroatom substituted β-phenylpropanoic acids

David Haigh, Stephen A. Smith, M. Cawthorne, 1996 .

Facile biocatalytic reduction of the carbon–carbon double bond of 5-benzylidenethiazolidine-2,4-diones. Synthesis of (±)-5-(4-{2-[methyl(2-pyridyl)amino]ethoxy}benzyl)thiazolidine-2,4-dione (BRL 49653), its (R)-(+)-enantiomer and analogues

D. Eggleston, R. Haltiwanger, R. M. Hindley, 1994 .

Relationship between the microscopic and macroscopic world in optical oxygen sensing: a luminescence lifetime microscopy study.

G. Orellana, Juan López-Gejo, D. Haigh, 2010, Langmuir : the ACS journal of surfaces and colloids.

Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.

J. Holder, J. Clapham, H. Chapman, 1998, The Journal of pharmacology and experimental therapeutics.

Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure.

Angela Smallwood, Ping Wang, David Haigh, 2005, Journal of medicinal chemistry.

Non-thiazolidinedione antihyperglycaemic agents. Part 3 : The effects of stereochemistry on the potency of α-methoxy-β-phenylpropanoic acids

Stephen A. Smith, J. Holder, D. Eggleston, 1999 .

3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

M. Saunders, R. Ife, D. Haigh, 2001, Bioorganic & medicinal chemistry letters.

Non-thiazolidinedione antihyperglycaemic agents. Part 4: Synthesis of (±)-, (R)-(+)- and (S)-(−)-enantiomers of 2-oxy-3-arylpropanoic acids

H. Birrell, H. Rami, D. Haigh, 1999 .